These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 6663752
21. [Comparison of urinary N-acetyl-beta-D-glucosaminidase activity determined by using 24-hour and 2-hour urine]. Uno E, Sano-Shiba K, Ida T, Sakurai S. Rinsho Byori; 1986 May; 34(5):590-4. PubMed ID: 3761626 [No Abstract] [Full Text] [Related]
22. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)]. Oudart N, Marcher K, Lacour B, Boulu RG, Guichard C. Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165 [Abstract] [Full Text] [Related]
23. Expression modes of urinary N-acetyl-beta-D-glucosaminidase in patients with chronic renal insufficiency. Tassi C, Mancuso F, Feligioni L, Marangi M, Capodicasa E. Clin Chim Acta; 2004 Aug 16; 346(2):129-33. PubMed ID: 15256313 [Abstract] [Full Text] [Related]
24. Varied value of urinary N-acetyl-beta-D-glucosaminidase isoenzyme B in males of reproductive age. Itoh Y, Numata Y, Morita A, Asano Y, Kawai T. Kidney Int Suppl; 1994 Nov 16; 47():S38-42. PubMed ID: 7869670 [Abstract] [Full Text] [Related]
25. Levels of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity versus arterial hypertension. Laterza G, Clemenzia G, Gentile V, Bassano F, Scibinetti F, Russo G. Panminerva Med; 1984 Nov 16; 26(2):101-3. PubMed ID: 6483455 [No Abstract] [Full Text] [Related]
26. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity]. Matsuoka R, Inoue T, Miyamura K, Mizutani K, Koike S, Mori H, Kigawa T. Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov 16; 38(11):2037-44. PubMed ID: 3794453 [Abstract] [Full Text] [Related]
27. [Measurement of creatinine clearance and urinary NAG for the evaluation of cis-platinum induced nephrotoxicity]. Kubota A, Yoshida T, Tsukuda M, Furukawa S, Miyata K, Mochimatsu I, Sawaki S. Gan To Kagaku Ryoho; 1989 Aug 16; 16(8 Pt 1):2599-605. PubMed ID: 2774590 [Abstract] [Full Text] [Related]
28. [Fundamental studies on the measurement of urinary NAG and determination of the normal values for NAG activity in various age groups]. Iimura Y, Shimada I, Ohnuki Y, Noguchi H, Kawai T, Asano Y, Kawana H. Rinsho Byori; 1983 Feb 16; 31(2):179-84. PubMed ID: 6854998 [No Abstract] [Full Text] [Related]
29. [Clinical evaluation of urinary n-acetyl-beta-d-glucosaminidase activity in patients treated with aminoglycosides]. Hirokawa N, Naruse T. Nihon Jinzo Gakkai Shi; 1982 Sep 16; 24(9):1041-53. PubMed ID: 7161951 [No Abstract] [Full Text] [Related]
30. Excretion of urinary N-acetyl-beta-D-glucosaminidase B in renal disorders & renal transplantation. Basu D, Joseph R, Raman PT, Johny KV. Indian J Biochem Biophys; 1977 Mar 16; 14(1):77-9. PubMed ID: 336518 [No Abstract] [Full Text] [Related]
31. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase. Hsu WS, Kao JT, Chen JS. Taiwan Yi Xue Hui Za Zhi; 1989 Apr 16; 88(4):407-9. PubMed ID: 2571671 [Abstract] [Full Text] [Related]
32. [N-acetyl-beta-D-glucosaminidase: a sensible enzyme to functional and morphologic renal changes]. Kopf SR, Nahmod VE. Medicina (B Aires); 1988 Apr 16; 48(2):215-6. PubMed ID: 3231086 [No Abstract] [Full Text] [Related]
33. [Influence of aminoglycosides on the activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzymes]. Mozer JL, Gibey R, Dupond JL, Henry JC. Pathol Biol (Paris); 1988 Mar 16; 36(3):230-4. PubMed ID: 3283685 [Abstract] [Full Text] [Related]
34. [Clinical and diagnostic significance of microalbuminuria and activity of tubular enzyme N-acetyl-beta-D-glucosaminidase (NAG) determination in patients with hyperuricosuria]. Lebedeva MV, Balkarov IM, Lukicheva TI, Men'shikov VV, Mukhin NA, Varshavskĭ VA, Proskurneva EP, Aleksandrovaskaia TN. Ter Arkh; 1998 Mar 16; 70(4):48-54. PubMed ID: 9612904 [Abstract] [Full Text] [Related]
35. [Relation of enzyme distribution in the kidney and increase pattern of urinary N-acetyl-beta-D-glucosaminidase (NAG) and gamma-glutamyl transpeptidase (gamma-GTP) activities following CDDP administration]. Takahashi T, Yoshida K, Nakame Y, Saitoh H. Hinyokika Kiyo; 1987 Oct 16; 33(10):1569-74. PubMed ID: 2895573 [Abstract] [Full Text] [Related]
36. [Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients with urological disease: with special reference to hydronephrosis]. Ueda K, Kato J, Seki T. Hinyokika Kiyo; 1984 Jul 16; 30(7):877-82. PubMed ID: 6391119 [Abstract] [Full Text] [Related]
37. [Influences of percutaneous nephrolithotomy on renal function, an observation using the NAG-index and beta 2-microglobulin as indices]. Yajima I, Nishimura T, Yoshida K, Tomita M, Hikima N, Kawamura N, Tsuboi N, Honda R, Akimoto M. Hinyokika Kiyo; 1987 May 16; 33(5):662-8. PubMed ID: 3310555 [Abstract] [Full Text] [Related]
38. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin]. Crovato E, Salvini R. Boll Soc Ital Biol Sper; 1984 Dec 30; 60(12):2255-60. PubMed ID: 6543318 [Abstract] [Full Text] [Related]
39. Comparison of the effect of aminoglycosides on excretion of N-acetyl-beta-glucosaminidase. Fujita K, Murayama T, Kawamura M, Narita K. Int J Clin Pharmacol Res; 1987 Dec 30; 7(6):477-80. PubMed ID: 3440638 [Abstract] [Full Text] [Related]
40. [A comparison between the urinary and serum NAG activity in subjects with chronic nephropathies and essential arterial hypertension]. Persichetti S, Clemenzia G, Laterza G, Sagliaschi G, Spinelli C, Gallo G, Re M, Fagioli A, Punzo G, Angelitti A. Minerva Med; 1990 Apr 30; 81(4):265-70. PubMed ID: 2342652 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]